Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity.
- Published In:
- Peptides, 162, 170955 (2023)
- Authors:
- Zhihong, Yao, Chen, Wang, Qianqian, Zhu, Lidan, Sun, Qiang, Zhou, Jing, Han, Wenxi, Wang, Bhawal, Ruchika
- Database ID:
- RPEP-07642
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07642APA
Zhihong, Yao; Chen, Wang; Qianqian, Zhu; Lidan, Sun; Qiang, Zhou; Jing, Han; Wenxi, Wang; Bhawal, Ruchika. (2023). Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity.. Peptides, 162, 170955. https://doi.org/10.1016/j.peptides.2023.170955
MLA
Zhihong, Yao, et al. "Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity.." Peptides, 2023. https://doi.org/10.1016/j.peptides.2023.170955
RethinkPeptides
RethinkPeptides Research Database. "Emerging roles of oxyntomodulin-based glucagon-like peptide-..." RPEP-07642. Retrieved from https://rethinkpeptides.com/research/zhihong-2023-emerging-roles-of-oxyntomodulinbased
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.